Herlev Hospital, University of Copenhagen

Herlev 2730

0 studies enrolling now · 3 studies all time

What they study most

Colitis, Ulcerative, Crohn's Disease, Fibrostenotic Crohn's Disease

Studies at this site

• A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
• STENOVA - A Study to Evaluate Safety, Tolerability, PK and PD of AGMB-129 in Patients With Fibrostenotic Crohn's Disease — Completed
• A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling